- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- People at high risk of STIs
- Men who have sex with men
- People living with HIV
- Hospital
- Outpatient clinic
- Infectious diseases unit
- Monkeypox virus
Population: Fragile population
Individuals who are more vulnerable to poor health outcomes due to factors like chronic illness, weakened immune systems, disabilities or socioeconomic disadvantages
- Adults (18-64 years)
- Fragile population
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Molnupiravir
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Hospital
- Intensive care unit
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Fragile population
- Immunocompromised host
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Adults (18-64 years)
- Fragile population
- People at high risk of STIs
- Immunocompromised host
- PrEP users
- People living with HIV
- Non-hospital health centre
- Telemedicine
- Monkeypox virus
- Pharmacological intervention
- Vaccination
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Immunocompromised host
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Pharmacological intervention
- Monoclonal antibodies
- AZD3152/Sipavibart
- Adults (18-64 years)
- Fragile population
- People at high risk of STIs
- Immunocompromised host
- PrEP users
- People living with HIV
- Hospital
- Outpatient clinic
- Infectious diseases unit
- Monkeypox virus
- Adults (18-64 years)
- Fragile population
- People at high risk of STIs
- Immunocompromised host
- PrEP users
- People living with HIV
- Outpatient clinic
- Non-hospital health centre
- STD/STI clinic
- Monkeypox virus
- Adults (18-64 years)
- Fragile population
- SARS-CoV-2
- Post COVID-19 condition
- Post-acute infection syndrome
- Adults (18-64 years)
- Fragile population
- People at high risk of STIs
- Immunocompromised host
- Men who have sex with men
- People living with HIV
- Hospital
- Monkeypox virus
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Immunocompromised host
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Outpatient clinic
- Community
- Non-hospital health centre
- SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Monoclonal antibodies
- Nirmatrelvir/Ritonavir
- Sotrovimab
- Molnupiravir